Skip to main content

Keel Point, LLC

SEC CIK
0001386935
Latest filing
Aug 14, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Keel Point, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of EW by Keel Point, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−5,149−100.0%Sold outHolders
Q4 20255,149$438.9K<0.1%−142−2.7%ReducedHolders
Q3 20255,291$411.5K<0.1%+199+3.9%AddedHolders
Q2 20255,092$398.2K<0.1%−230−4.3%ReducedHolders
Q1 20255,322$385.7K<0.1%+508+10.6%AddedHolders
Q4 20244,814$356.4K<0.1%+976+25.4%AddedHolders
Q3 20243,838$253.3K<0.1%−135−3.4%ReducedHolders
Q2 20243,973$263.6K<0.1%+924+30.3%AddedHolders
Q1 20243,049$291.4K<0.1%+13+0.4%AddedHolders
Q4 20233,036$231.5K<0.1%+91+3.1%AddedHolders
Q3 20232,945$204.0K<0.1%−156−5.0%ReducedHolders
Q2 20233,101$292.5K<0.1%+140+4.7%AddedHolders
Q1 20232,961$245.0K<0.1%+107+3.7%AddedHolders
Q4 20222,854$212.9K<0.1%−122−4.1%ReducedHolders
Q3 20222,976$246.0K<0.1%+89+3.1%AddedHolders
Q2 20222,887$300.0K<0.1%−565−16.4%ReducedHolders
Q1 20223,452$406.0K0.1%+154+4.7%AddedHolders
Q4 20213,298$427.0K0.1%+234+7.6%AddedHolders
Q3 20213,064$347.0K<0.1%−28−0.9%ReducedHolders
Q2 20213,092$320.0K<0.1%+118+4.0%AddedHolders
Q1 20212,974$249.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.